2012
Despite side effects including N-methyl-d-aspartate-mediated neurotoxicity, recombinant tissue-type plasminogen activator (rtPA) remains the only approved acute treatment for ischemic stroke. (…)
Consulter 
2012
Recombinant tissue plasminogen activator (rt-PA) is currently the only approved drug for ischemic stroke treatment, with a dose of 0.9 (…)
Consulter
2012
Consulter
2012
Tissue plasminogen activator (tPA) is a serine protease with pleiotropic actions in the CNS, such as synaptic plasticity and neuronal (…)
Consulter
2013
Implanted cortical stimulation is foreseen to facilitate functional poststroke recovery. Until now, no study has concluded on its pathophysiological mechanism. (…)
Consulter
2013
Glutamate excitotoxicity is a consolidated hypothesis in neonatal brain injuries and tissue plasminogen activator (t-PA) participates in the processes through (…)
Consulter
